Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Inter Biosolutions ApS
APS
Active
CVR 43014757
Fruebjergvej 3
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
10 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -886K
EBITDA margin
100.0%
-4626% vs 2023
Equity ratio
-46.3%
Financial strength
Net profit 2024
DKK -486K
-3225% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
0%
2023
-1M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK -886K
—
EBITDA
DKK -886K
-4626%
Net profit
DKK -486K
-3225%
Total assets
DKK 1M
+732%
Equity
DKK -467K
-2548%
Employees
10
—
Company information
Legal name
Inter Biosolutions ApS
CVR number
43014757
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26. januar 2022
Share capital
DKK 43.750
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at bedrive forskning og udvikling samt anden virksomhed der efter direktionens skøn er beslægtet dermed.
Contact
Address
Fruebjergvej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
-1M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
-1M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
0
0
-886
Staff expenses
-0
-0
-0
EBITDA
-8
-19
-886
Depreciation & amort.
-0
-0
-0
EBIT
-8
-19
-886
Net financials
-0
0
205
Profit before tax
-8
-19
-681
Tax
-0
-4
-195
Net profit
-8
-15
-486
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
136
121
1.008
Equity
34
19
-467
Long-term debt
0
0
0
Short-term debt
102
102
1.475
Total debt
102
102
1.475
Financial ratios
5-year trend
EBITDA margin
-88604100.0%
This company
15.8%
Market median
-560785543% vs market
2022
2024
Equity ratio
-46.3%
This company
38.2%
Market median
-221% vs market
2022
2024
Return on equity
-48594600.0%
This company
18.4%
Market median
-264101187% vs market
2022
2024
Net profit margin
-48594600.0%
This company
8.1%
Market median
-599933433% vs market
2022
2024
Asset turnover
-0.88×
This company
1.12×
Market median
-179% vs market
2022
2024
Debt / equity
3.16×
This company
0.62×
Market median
-410% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-26 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
KH
Klaus Hjortenberg Kroll
Management
Management
2024
—
—
CP
Carsten Pedersen Rise
Founder
Founder
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kobo ApS
Company
66.7%
66.7%
2024
STEEN BRUMMERSTEDT IVERSEN ApS
Company
20.0%
20.0%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Kobo ApS
Inter Biosolutions ApS
(this company)
Board network connections
Board members of Inter Biosolutions ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Klaus Hjortenberg Kroll
Management
0 companies
Carsten Pedersen Rise
Founder
0 companies